Deep Tech Startups

Myka Labs develops AI-powered sensor systems and medical devices for minimally invasive surgical repair of congenital birth defects, particularly tracheoesophageal malformations. The company creates sensorized catheters and imaging augmentation technology for pediatric and general surgeons.

1 investor

Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.

1 investor

Myriad Wind Energy Systems develops wind energy technology, founded by three PhD researchers from the Wind and Marine Centre for Doctoral Training. The company is based in Scotland and focuses on innovation in the wind energy sector.

1 investor

Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders. The company's precision medicines aim to promote remyelination and reduce neuroinflammation in conditions such as multiple sclerosis, Alzheimer's disease, and ALS.

1 investor

Mystiko is a zero-knowledge (ZK) infrastructure and protocol project, providing whitepapers, documentation, compliance tools, and an explorer around its $XZK token and community governance. It operates in the crypto and blockchain space with a focus on ZK technology.

1 investor

Mythos AI develops artificial intelligence technology for maritime operations. The company operates in the maritime and AI technology sector.

1 investor

One3D is a cloud-based photogrammetry platform that converts drone or camera images into survey-grade 3D models, orthophotos, and point clouds accessible through a web browser for measurement, inspection, and sharing.

1 investor

NLEVEL develops real-time energy routing technology to create a decentralized, self-healing energy network that prevents power outages by intelligently routing electricity around faults. The company serves energy infrastructure operators and utilities to enable more reliable power distribution.

1 investor

N15 is a hardware accelerator and open innovation platform that connects startups, large corporations, and public institutions to support manufacturing and commercialization of hardware products in South Korea. The company provides expert infrastructure, investment connections, and manufacturing expertise to bring ideas from concept to market.

1 investor

N2TP builds autonomous AI systems with formal mathematical verification for life science R&D, aiming to make AI-driven hypotheses and experiments reproducible and trustworthy. Its platform powers applications including SmartDoseAI for model-informed precision dosing of narrow-therapeutic-window drugs and the LynxDetect programmable biosensor for point-of-care diagnostics.

1 investor

n6 is a genomics technology company that develops methods and tools for molecular R&D and genomics research. The company serves researchers and genomics labs.

1 investor

Nabu Optical Systems develops maskless lithography tools that combine projection lithography and direct laser writing using virtual masks, targeting the 180–500 nm node segment. The systems are aimed at small and medium enterprises, startups, and research, university, and government labs in the semiconductor manufacturing industry.

1 investor

NALA Membranes develops patented polymer-based membrane technology for desalination and water treatment applications. The company serves industrial water and energy sectors with advanced membrane manufacturing expertise.

1 investor

Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.

1 investor

Nano Dimension (Nasdaq: NNDM) makes additive manufacturing machines, including Additively Manufactured Electronics (AME) systems for fabricating printed circuit boards in-house and Fabrica micro-AM 3D printers, integrated with factory robotics and deep-learning AI. Its systems serve R&D labs, designers, and engineers in electronics, medicine, aerospace, and scientific research.

1 investor

Nanosummit develops industrial-scale technology to uniformly disperse carbon nanotubes (CNT) and other carbon-based nanomaterials at low cost, addressing CNT aggregation problems. Its dispersion technology enables CNT-based coatings and composites used in products such as heat-generating sheets, conductive fibers, and cesium-adsorbing filters.

1 investor

NanoBio Designs develops nanotechnology-based assays and detection devices that use microparticle pairing to visibly identify target DNA sequences and genetic markers in grain samples such as soybeans. The company serves the agriculture and grain-processing industry, with operations in Indiana and Iowa.

1 investor

NanoBridge Semiconductor, Inc. develops NanoBridge semiconductor technologies designed for low power consumption and harsh operating environments. Its main product areas include NanoBridge FPGA (NBFPGA) and NanoBridge Non-Volatile Memory (NBNVM).

1 investor

NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.

1 investor

Nano Catalytics develops patent-pending nano and micro particles that, when activated by radio frequency, release catalysts to trigger polymerization on demand, allowing manufacturers to cure adhesives and parts without heating the entire object. Sold as ready-to-use additives to formulators, the technology currently targets the adhesives market and is aimed at chemical and manufacturing applications.</parameter> <parameter name="founders">[{"full_name": "Adam Malofsky", "title": "CEO"}, {"full_name": "Steve Levin", "title": "COO"}]

1 investor

NanoDx develops point-of-care diagnostic devices using nanowire biosensor technology to deliver rapid test results at patient locations, targeting unmet clinical needs globally.

1 investor

NanoFrontier develops and commercializes nanoparticle technologies derived from Tohoku University, enabling cost-effective solutions for water contamination detection, next-generation battery systems, cooling performance, hydrogen transport, and drug delivery applications. The company offers custom nanoparticle development, contract manufacturing, and technology licensing to industrial and research customers.

1 investor

NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads. The biotech company's technology originates from research at the Technion – Israel Institute of Technology.

1 investor

Nanogrande develops and sells precision 3D printing systems using patented FluidBed technology, alongside materials and engineering services. The company serves R&D organizations and industrial manufacturers seeking high-precision additive manufacturing with improved material efficiency and reduced environmental impact.

1 investor